Related Experiment Video
Updated: Feb 9, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Trends of testing for and diagnosis of α1-antitrypsin deficiency in the UK: more testing is needed
Joan B Soriano1, Sarah J Lucas2, Rupert Jones3
1Instituto de Investigación Hospital Universitario de la Princesa (IISP), Universidad Autónoma de Madrid and SEPAR, Madrid, Spain.
Insights
Alpha-1 antitrypsin deficiency (AATD) testing remains low in COPD patients, with only 2.2% tested before age 60. Despite increased testing, AATD is significantly underdiagnosed in this population.
Area of Science:
- Pulmonology
- Genetics
- Epidemiology
Background:
- Alpha-1 antitrypsin deficiency (AATD) is a genetic condition that significantly increases the risk of developing chronic obstructive pulmonary disease (COPD).
- International guidelines recommend testing all COPD patients for AATD due to its strong association with the disease.
Purpose of the Study:
- To analyze trends in AATD testing and diagnosis among COPD patients in the UK from 1990 to 2014.
- To assess the prevalence of AATD in COPD patients diagnosed before the age of 60.
Main Methods:
- Retrospective analysis of the UK Optimum Patient Care Research Database.
- Inclusion of approximately 107,024 individuals diagnosed with COPD.
- Subgroup analysis of patients diagnosed with COPD before age 60.
Main Results:
- Only 2.2% of COPD patients diagnosed before age 60 had a record of AATD testing.
- Among those tested, 23.7% were diagnosed with AATD.
- AATD diagnosis was associated with male gender, ex-smoker status, more severe COPD, and higher GOLD stages.
Conclusions:
- Despite recommendations and a general increase in testing, AATD remains significantly underdiagnosed in COPD patients.
- Current testing rates suggest a substantial gap in identifying individuals with AATD among the COPD population.
Abstract:
α1-antitrypsin deficiency (AATD) significantly increases the risk of developing chronic obstructive pulmonary disease (COPD), and testing of all COPD patients for AATD is recommended by the World Health Organization, European Respiratory Society and Global Initiative for Chronic Obstructive Lung Disease (GOLD). We aimed to determine trends for testing and diagnosing AATD from 1990 to 2014.This study analysed all patients diagnosed with COPD from about 550 UK Optimum Patient Care Research Database general practices, including a subgroup of those diagnosed before the age of 60 years.We identified 107 024 COPD individuals, of whom 29 596 (27.6%) were diagnosed before 60 years of age. Of them, only 2.2% (95% CI 2.09-2.43%) had any record of being tested for AATD. Of those tested, 23.7% (95% CI 20.5-27.1%) were diagnosed with AATD. Between 1994 and 2013 the incidence of AATD diagnosis generally increased. A diagnosis of AATD was associated with being male, being an ex-smoker, more severe COPD with a lower forced expiratory volume in 1 s % pred and higher GOLD 2017 stages (all p<0.05).Despite an increase in the frequency of AATD testing since 1990, only 2.2% of patients diagnosed with COPD before the age of 60 years were tested. AATD prevalence was 23.7% in those tested. Thus, it appears that AATD remains markedly underdiagnosed in COPD patients.
Related Concept Videos
Testes: Histology
The spermatogenic cells, responsible for producing sperm, are...
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Significance Testing: Overview
Testes: Gross Anatomy
Each testis is surrounded by the tunica albuginea, a dense connective tissue layer that provides structural support and protection. This layer is covered by an outer serous membrane called the tunica vaginalis, which helps reduce friction...
Testing Water Quality
Types of Hypothesis Testing
When the null and alternative hypotheses are stated, it is observed that the null hypothesis is a neutral statement against which the alternative hypothesis is tested. The alternative hypothesis is a claim that instead has a certain direction. If the null hypothesis claims that p = 0.5, the alternative hypothesis would be an opposing statement to this and can be put either p > 0.5, p < 0.5, or p...

